Abstract
Abstract Objective To investigate the correlation between serum homocysteine (Hcy), Galectin-3 concentration and atrial structural remodeling in atrial fibrillation (AF) patients. Methods Twenty-five patients with persistent atrial fibrillation (PeAF), 24 patients with paroxysmal atrial fibrillation (PaAF) and 23 healthy controls were included in the present work. All subjects received an echocardiography examination. Serum concentration of Hcy and Galectin-3 were also examined by Enzyme Linked Immunosorbent Assay (ELISA). Results Echocardiography examination demonstrated that there were significant differences for LAD (p=0.002), LVEF (p=0.005) and LVAI (p=0.0001) between the control, PaAF and PeAF groups. However, LVSD and LVDD were not significantly different between the three groups (pall>0.05). There was a significant positive correlation between LAVI and serum Hcy level in both PaAF (rpearson=0.49, p=0.016) and PeAF (rpearson=0.51, p=0.009) groups. The correlation between LAVI and serum Galectin-3 concentration was also statistically significant for PaAF (rpearson=0.54, p=0.006) and PeAF (rpearson=0.60, p=0.001) groups. Using serum Hcy as reference, diagnostic sensitivity and specificity were calculated as 72.00 (95%CI: 50.61-87.93) and 62.50 (95%CI: 40.59-81.20), respectively, with an AUC of 0.68 for PaAF and PeAF. For serum Galectin-3, the sensitivity and specificity values were 64.00 (95%CI:42.52-82.03) and 66.67 (95%CI:44.68-84.37), respectively, with an AUC of 0.68. Conclusion: Serum Hcy and Galectin-3 were elevated in AF patients and thus may be potential markers of atrial structural remodeling. However, the diagnostic efficacy of PeAF from PaAF was limited by low AUC values.
Highlights
Atrial fibrillation (AF) is one of the most common arrhythmias seen in clinical practice
Serum Hcy and Galectin-3 were elevated in AF patients and may be potential markers of atrial structural remodeling
The diagnostic efficacy of persistent atrial fibrillation (PeAF) from paroxysmal atrial fibrillation (PaAF) was limited by low AUC values
Summary
Atrial fibrillation (AF) is one of the most common arrhythmias seen in clinical practice. As the proportion of older persons in a population continues to increase, so does the incidence of atrial fibrillation. AF can lead to hemodynamic changes, left atrial thrombosis, and increased risk of stroke and heart failure. It is associated with a high rate of death or disability. Basic research on atrial fibrillation has made encouraging progress, and novel treatment methods (such as radiofrequency catheter ablation) have improved the prognoses of AF patients. The recurrence rate after traditional drug therapy and radiofrequency catheter ablation remains high, especially in patients with persistent atrial fibrillation. Despite the great harm caused by AF, treatment options remain limited; it is of great significance to identify the mechanism of occurrence, development and maintenance of AF
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have